Identification of specific lung cancer pathway increases the ability to predict which patients are likely or unlikely to benefit from a particular treatment, reveals a new study. The findings of the study are published in the journal iCancer Cell/i.
Known for its poor prognosis, lung adenocarcinoma is the most common type of lung cancer, responsible for about 4 of 10 diagnoses, according to the National Cancer Institute. Researchers on Mayo Clinic's Florida campus can now distinguish between ...
Identification of specific lung cancer pathway increases the ability to predict which patients are likely or unlikely to benefit from a particular treatment, reveals a new study. The findings of the study are published in the journal iCancer Cell/i.
Known for its poor prognosis, lung adenocarcinoma is the most common type of lung cancer, responsible for about 4 of 10 diagnoses, according to the National Cancer Institute. Researchers on Mayo Clinic's Florida campus can now distinguish between ...